acute myocardial infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Interventions
Intervention 1: Control group: Patients in this group will be treated Atorostatin 80 mg, the first dose will be prescribed in the emergency department and the other doses will be continuous. Interven
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients who are candidates primary percutaneous intervention with acute myocardial infarction with ST-segment elevation are admitted to the emergency department of Madani heart center of Tabriz.
Exclusion criteria
Exclusion criteria: The patients with chronic disease such as inflammatory diseases, renal failure, a history of collagen and vascular disease, current active infection, blood diseases. The patients with history of acute myocardial infarction or ischemic heart disease. The patients with history of diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of no-reflow at the during of PPCI. Timepoint: once at the during of the PPCI. Method of measurement: observational and based on individual skills.;Rate of TIMI flow at the end of PPCI. Timepoint: once at the end of the PPCI. Method of measurement: observational and based on individual skills. | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of mortality. Timepoint: During hospitalization. Method of measurement: Observational. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNaser Khalili
Tabriz University of Medical Sciences
Outcome results
None listed